- Main
Aberrant splicing in Huntingtons disease accompanies disrupted TDP-43 activity and altered m6A RNA modification.
- Nguyen, Thai;
- Miramontes, Ricardo;
- Chillon-Marinas, Carlos;
- Maimon, Roy;
- Vazquez-Sanchez, Sonia;
- Lau, Alice;
- McClure, Nicolette;
- Wu, Zhuoxing;
- Wang, Keona;
- England, Whitney;
- Singha, Monika;
- Stocksdale, Jennifer;
- Heath, Marie;
- Jang, Ki-Hong;
- Jung, Sunhee;
- Ling, Karen;
- Jafar-Nejad, Paymann;
- McKnight, Jharrayne;
- Ho, Leanne;
- Dalahmah, Osama;
- Faull, Richard;
- Steffan, Joan;
- Reidling, Jack;
- Jang, Cholsoon;
- Lee, Gina;
- Cleveland, Don;
- Lagier-Tourenne, Clotilde;
- Spitale, Robert;
- Thompson, Leslie
- et al.
Published Web Location
https://doi.org/10.1038/s41593-024-01850-wAbstract
Huntingtons disease (HD) is caused by a CAG repeat expansion in the HTT gene, leading to altered gene expression. However, the mechanisms leading to disrupted RNA processing in HD remain unclear. Here we identify TDP-43 and the N6-methyladenosine (m6A) writer protein METTL3 to be upstream regulators of exon skipping in multiple HD systems. Disrupted nuclear localization of TDP-43 and cytoplasmic accumulation of phosphorylated TDP-43 occurs in HD mouse and human brains, with TDP-43 also co-localizing with HTT nuclear aggregate-like bodies distinct from mutant HTT inclusions. The binding of TDP-43 onto RNAs encoding HD-associated differentially expressed and aberrantly spliced genes is decreased. Finally, m6A RNA modification is reduced on RNAs abnormally expressed in the striatum of HD R6/2 mouse brain, including at clustered sites adjacent to TDP-43 binding sites. Our evidence supports TDP-43 loss of function coupled with altered m6A modification as a mechanism underlying alternative splicing in HD.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.
Main Content
Enter the password to open this PDF file:
-
-
-
-
-
-
-
-
-
-
-
-
-
-